HIV/AIDS Research
CypA effects HIV-1 replicative ability such that both high and low CypA limits replication
Published in Medical Letter on the CDC and FDA, March 12th, 2006
"HIV-1 Gag protein interaction with cyclophilin A (CypA) is critical for viral fitness. Among the amino acid substitutions identified in Gag noncleavage sites in HIV-1 variants resistant to protease inhibitors, H219Q (Gatanaga, H. et al., (2002) J. Biol. Chem. 277, 5952-5961) and H219P substitutions in the viral CypA binding loop confer the greatest replication advantage to HIV-1. These substitutions represent polymorphic amino acid residues," scientists writing in the Journal of Biological Chemistry report.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Cryptosporidiosis Outbreaks
Cryptosporidiosis outbreak associated with swimming pool exposure in water park - Human Papillomavirus Vaccine
Cervical mucosal antibodies protect against human papillomavirus 16 - Public Health
Pneumococcal vaccine in children decreases pneumococcal disease in HIV+ adults - Sexual & Reproductive Health
STD male-to-female ratio provides clues to behavior changes in men who have sex with men - Virology
One step, real time RT-PCR assay to detect hepatitis E virus has been developed - Acute Ischemic Stroke
Biopharma company to start phase IIa study with neuroprotectant Enecadin in acute ischemic stroke - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
